In-vivo studies: ORGANOID-DERIVED XENOGRAFT (ODX) and patient-derived xenograft (pdx)

For improved and more effective drug development, in-vivo models ensure smooth transition from early phase in-vitro drug target identification to later stages of compound efficacy and potency validation in-vivo. In this respect, we have organoids derived xenografts and direct xenotransplants of cancer tissues for more physiological relevant in-vivo studies on therapeutic effects.   

Liver cancer ODX

ODX growth curves

6-week post implantation